Ryan Specialty (RYAN) — insider trading
Financials · NYSE
Ryan Specialty (RYAN) has 41 reported SEC Form 4 insider transactions in our data, including 6 open-market purchases and 2 open-market sales among the most recent 41 (latest 2026-09-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | MULSHINE BRENDAN MARTIN | Officer (Co-President and CRO) | Open-market sale | 40,000 | $40.51 | $1.62M | Form 4 |
| 2026-09-04 | MULSHINE BRENDAN MARTIN | Officer (Co-President and CRO) | Conversion of derivative (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-09-04 | MULSHINE BRENDAN MARTIN | Officer (Co-President and CRO) | Conversion of derivative | 40,000 | — | $0 | Form 4 |
| 2026-09-04 | MULSHINE BRENDAN MARTIN | Officer (Co-President and CRO) | Conversion of derivative | 40,000 | — | $0 | Form 4 |
| 2026-08-14 | CORTEZI NICHOLAS DOMINIC | Director | Other acquisition or disposition (derivative) | 313,116 | — | $0 | Form 4 |
| 2026-08-14 | CORTEZI NICHOLAS DOMINIC | Director | Other acquisition or disposition (derivative) | 1,841,019 | — | $0 | Form 4 |
| 2026-08-14 | CORTEZI NICHOLAS DOMINIC | Director | Other acquisition or disposition | 313,116 | — | $0 | Form 4 |
| 2026-08-14 | CORTEZI NICHOLAS DOMINIC | Director | Other acquisition or disposition | 1,841,019 | — | $0 | Form 4 |
| 2026-08-13 | Conklin Michael | Officer (EVP & CHRO) | Open-market sale | 2,043 | $42.26 | $86.3K | Form 4 |
| 2026-08-10 | Bienen Henry S | Director | Bona fide gift | 3,000 | — | $0 | Form 4 |
| 2026-08-04 | Keogh Stephen Patrick | Officer (Co-President and COO) | Grant / award / vesting (derivative) | 22,920 | — | $0 | Form 4 |
| 2026-08-04 | Conklin Michael | Officer (EVP & CHRO) | Grant / award / vesting (derivative) | 22,920 | — | $0 | Form 4 |
| 2026-08-04 | RYAN PATRICK G | Director, Officer (Executive Chairman), 10% owner | Disposition to the issuer (derivative) | 287,646 | — | $0 | Form 4 |
| 2026-07-22 | Hamilton Janice M | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 5,821 | — | $0 | Form 4 |
| 2026-07-22 | Hamilton Janice M | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,706 | $40.89 | $69.8K | Form 4 |
| 2026-07-22 | Hamilton Janice M | Officer (Chief Financial Officer) | Option exercise / conversion | 5,821 | — | — | Form 4 |
| 2026-06-12 | Kuczinski Anthony J | Director | Open-market purchase | 500 | $35.77 | $17.9K | Form 4 |
| 2026-06-11 | Kuczinski Anthony J | Director | Open-market purchase | 2,500 | $34.83 | $87.1K | Form 4 |
| 2026-06-10 | ROGERS JOHN W JR | Director | Open-market purchase | 7,500 | $35.16 | $263.7K | Form 4 |
| 2026-06-05 | RYAN PATRICK G | Director, Officer (Executive Chairman), 10% owner | Open-market purchase | 120,000 | $32.50 | $3.90M | Form 4 |
| 2026-06-03 | KATZ MARK STEPHEN | Officer (EVP & General Counsel) | Open-market purchase | 3,215 | $31.07 | $99.9K | Form 4 |
| 2026-06-03 | Hamilton Janice M | Officer (Chief Financial Officer) | Open-market purchase | 6,300 | $31.79 | $200.3K | Form 4 |
| 2026-05-29 | Bienen Henry S | Director | Bona fide gift | 2,700 | — | $0 | Form 4 |
| 2026-05-28 | Bienen Henry S | Director | Bona fide gift | 5,757 | — | $0 | Form 4 |
| 2026-05-28 | Bienen Henry S | Director | Bona fide gift | 5,757 | — | $0 | Form 4 |
| 2026-05-05 | RYAN PATRICK G | Director, Officer (Executive Chairman), 10% owner | Disposition to the issuer (derivative) | 1,787,446 | — | $0 | Form 4 |
| 2026-05-05 | Hamilton Janice M | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 33,715 | — | $0 | Form 4 |
| 2026-05-05 | Wuller Benjamin MIles | Officer (CEO RSUM) | Grant / award / vesting (derivative) | 33,715 | — | $0 | Form 4 |
| 2026-05-05 | KATZ MARK STEPHEN | Officer (EVP & General Counsel) | Grant / award / vesting (derivative) | 33,715 | — | $0 | Form 4 |
| 2026-05-05 | MULSHINE BRENDAN MARTIN | Officer (Co-President and CRO) | Grant / award / vesting (derivative) | 33,715 | — | $0 | Form 4 |
| 2026-05-05 | TURNER TIMOTHY WILLIAM | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 168,577 | — | $0 | Form 4 |
| 2026-04-28 | Bienen Henry S | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | BOLGER DAVID P | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | BUNGERT MICHAEL G | Director | Grant / award / vesting | 4,615 | — | $0 | Form 4 |
| 2026-04-28 | COLLINS MICHELLE L | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | Cornelli Francesca | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | CORTEZI NICHOLAS DOMINIC | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | Kuczinski Anthony J | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | OHALLERAN MICHAEL D | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | ROGERS JOHN W JR | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
| 2026-04-28 | RYAN PATRICK G JR | Director | Grant / award / vesting | 5,757 | — | $0 | Form 4 |
Ask the chat about RYAN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Ryan Specialty (RYAN).
Last updated 2026-09-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.